Clinical Trial Update: Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation

View source ↗

Summary

This clinical trial registry entry describes the Subxyphoid Hybrid MAZE Registry for patients with persistent atrial fibrillation, sponsored by the University o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: University of California, San Francisco | Conditions: Atrial Fibrillation, Persistent | Status: ENROLLING_BY_INVITATION